The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Jan. 11, 2016
Applicant:

Wake Forest University Health Sciences, Winston-Salem, NC (US);

Inventors:

Anthony Atala, Winston-Salem, NC (US);

Gayoung Jeong, Winston-Salem, NC (US);

James J. Yoo, Winston-Salem, NC (US);

Sang jin Lee, Winston-Salem, NC (US);

Young-Joon Seol, Winston-Salem, NC (US);

Assignee:

WAKE FOREST UNIVERSITY HEALTH SCIENCES, Winston-Salem, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/60 (2006.01); A61F 2/10 (2006.01); B33Y 80/00 (2015.01); B33Y 70/00 (2020.01); C08L 5/08 (2006.01); A61L 27/20 (2006.01); C08L 89/06 (2006.01); C12N 5/071 (2010.01); B33Y 10/00 (2015.01); B29C 64/106 (2017.01); A61L 27/18 (2006.01); A61L 27/38 (2006.01); A61L 27/52 (2006.01); G01N 33/50 (2006.01); B29K 75/00 (2006.01); B29K 105/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/60 (2013.01); A61F 2/10 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/3804 (2013.01); A61L 27/3813 (2013.01); A61L 27/3839 (2013.01); A61L 27/3891 (2013.01); A61L 27/52 (2013.01); B29C 64/106 (2017.08); B33Y 10/00 (2014.12); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); C08L 5/08 (2013.01); C08L 89/06 (2013.01); C12N 5/0698 (2013.01); G01N 33/502 (2013.01); G01N 33/5044 (2013.01); A61F 2210/0076 (2013.01); A61F 2240/001 (2013.01); A61L 2300/64 (2013.01); A61L 2430/34 (2013.01); B29K 2075/00 (2013.01); B29K 2105/0061 (2013.01); C12N 2502/091 (2013.01); C12N 2502/092 (2013.01); C12N 2502/094 (2013.01); C12N 2502/1305 (2013.01); C12N 2502/1323 (2013.01); C12N 2533/30 (2013.01); C12N 2533/54 (2013.01); C12N 2533/80 (2013.01);
Abstract

Provided are live, artificial, skin substitute products and methods of making and using the same, such as for wound treatment and compound testing, including compound testing for efficacy, toxicity, penetration, irritation and/or metabolism testing of drug candidates or compositions such as cosmetics. Described herein is an artificial mammalian skin substitute product, comprising: (a) optionally, but in some embodiments preferably, a first ('hypodermis-like') layer comprising live mammalian adipocytes (e.g., induced pre-adipocytes) in a first hydrogel carrier; (b) a second ('dermis-like') layer contacting or directly contacting the first layer and comprising live mammalian fibroblast cells and' live mammalian follicle dermal papilla cells in combination in a second hydrogel carrier; (c) a third (“epidermis-like”) layer contacting or directly contacting the second layer (i.e., on the opposite side thereof as the first layer, so that the second layer is sandwiched between the first and third layers when the first layer is present), the third layer comprising live mammalian keratinocytes and live mammalian melanocytes in combination in a third hydrogel carrier.


Find Patent Forward Citations

Loading…